Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells

World Journal of Gastroenterology

Volumn 20, Issue 38, 2014, Pages 13705-13717

  Minchenko, Oleksandr H ^a   Tsuchihara, Katsuya ^b   Minchenko, Dmytro O ^a,c   Bikfalvi, Andreas ^d   Esumi, Hiroyasu ^b  

^a PALLADIN INSTITUTE OF BIOCHEMISTRY   (Ukraine)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^c BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

6 phosphofructo 2 kinase fructose 2,6 bisphosphatase 3; 6 phosphofructo 2 kinase fructose 2,6 bisphosphatase 4; Gastric cancer; Hypoxia; Hypoxia inducible factor; Lung cancer; MKN45; NUGC3; Panc1; PST 1

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE FRUCTOSE 2,6 BISPHOSPHATASE 3; 6 PHOSPHOFRUCTO 2 KINASE FRUCTOSE 2,6 BISPHOSPHATASE 4; FRUCTOSE BISPHOSPHATASE; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; 6 PHOSPHOFRUCTO 2 KINASE; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; PFKFB3 PROTEIN, HUMAN; PFKFB4 PROTEIN, HUMAN; TUMOR MARKER;

BINDING SITE; BREAST CANCER; CANCER GROWTH; CANCER TISSUE; CELL PROLIFERATION; CELL SURVIVAL; COLON; COLON CANCER; GASTRIC CANCER CELL LINE; GENE CONTROL; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLYCOLYSIS; HUMAN; HYPOXIA; LUNG CANCER; LUNG PARENCHYMA; MALIGNANT NEOPLASTIC DISEASE; METABOLISM; MOLECULAR MECHANICS; NONHUMAN; PANCREATIC CANCER CELL LINE; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; STOMACH CANCER; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG DESIGN; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MOLECULARLY TARGETED THERAPY; PANCREATIC NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR MICROENVIRONMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOMARKERS, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG DESIGN; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR TARGETED THERAPY; PANCREATIC NEOPLASMS; PHOSPHOFRUCTOKINASE-2; RNA, MESSENGER; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84910015734     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i38.13705     Document Type: Review

References (95)

1. Vaccaro V, Gelibter A, Bria E, Iapicca P, Cappello P, Di Modugno F, Pino MS, Nuzzo C, Cognetti F, Novelli F, Nistico P, Milella M. Molecular and genetic bases of pancreatic cancer. Curr Drug Targets 2012; 13: 731-743 [PMID: 22458519 DOI: 10.2174/138945012800564077]
2. Thomas SJ, Swanik KA, Swanik C, Huxel KC. Glenohumeral rotation and scapular position adaptations after a single high school female sports season. J Athl Train 2009; 44: 230-237 [PMID: 19478845 DOI: 10.1002/jcb.22214]
3. Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001; 93: 266-276 [PMID: 11181773]
4. Neelam S, Brooks MM, Cammarata PR. Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia. Mol Vis 2013; 19: 1-15 [PMID: 23335846]
5. Chiche J, Rouleau M, Gounon P, Brahimi-Horn MC, Pouysségur J, Mazure NM. Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli. J Cell Physiol 2010; 222: 648-657 [PMID: 19957303 DOI: 10.1002/jcp.21984]
6. Brahimi-Horn MC, Chiche J, Pouysségur J. Hypoxia and cancer. J Mol Med (Berl) 2007; 85: 1301-1307 [PMID: 18026916 DOI: 10.1007/s00109-007-0281-3]
7. Chen C, Cai S, Wang G, Cao X, Yang X, Luo X, Feng Y, Hu J. c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α. Biochem Biophys Res Commun 2013; 430: 505-511 [PMID: 23237807 DOI: 10.1016/j.bbrc.2012.12.006]
8. Kim EJ, Simeone DM. Advances in pancreatic cancer. Curr Opin Gastroenterol 2011; 27: 460-466 [PMID: 21778878 DOI: 10.1097/MOG.0b013e328349e31f]
9. Ratcliffe PJ, O'Rourke JF, Maxwell PH, Pugh CW. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 1998; 201: 1153-1162 [PMID: 9510527]
10. Semenza GL. Involvement of hypoxia-inducible factor 1 in human cancer. Intern Med 2002; 41: 79-83 [PMID: 11868612]
11. Stoeltzing O, McCarty MF, Wey JS, Fan F, Liu W, Belcheva A, Bucana CD, Semenza GL, Ellis LM. Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst 2004; 96: 946-956 [PMID: 15199114 DOI: 10.1093/jnci/djh168]
12. Lu H, Forbes RA, Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 2002; 277: 23111-23115 [PMID: 11943784 DOI: 10.1074/jbc.M202487200]
13. Wykoff CC, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene 2000; 19: 6297-6305 [PMID: 11175344]
14. He Y, Kim H, Ryu T, Kang Y, Kim JA, Kim BH, Lee JH, Kang K, Lu Q, Kim K. δ-Catenin overexpression promotes angiogenic potential of CWR22Rv-1 prostate cancer cells via HIF-1α and VEGF. FEBS Lett 2013; 587: 193-199 [PMID: 23220088 DOI: 10.1016/j.febslet.2012.11.024]
15. Höpfl G, Ogunshola O, Gassmann M. HIFs and tumors - causes and consequences. Am J Physiol Regul Integr Comp Physiol 2004; 286: R608-R623 [PMID: 15003941 DOI: 10.1152/ajpregu.00538.2003]
16. Bartrons R, Caro J. Hypoxia, glucose metabolism and the Warburg's effect. J Bioenerg Biomembr 2007; 39: 223-229 [PMID: 17661163 DOI: 10.1007/s10863-007-9080-3]
17. Yalcin A, Telang S, Clem B, Chesney J. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. Exp Mol Pathol 2009; 86: 174-179 [PMID: 19454274 DOI: 10.1016/j.yexmp.2009.01.003]
18. Wolf A, Agnihotri S, Micallef J, Mukherjee J, Sabha N, Cairns R, Hawkins C, Guha A. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med 2011; 208: 313-326 [PMID: 21242296 DOI: 10.1084/jem.20101470]
19. Okar DA, Manzano A, Navarro-Sabatè A, Riera L, Bartrons R, Lange AJ. PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci 2001; 26: 30-35 [PMID: 11165514]
20. Rider MH, Bertrand L, Vertommen D, Michels PA, Rousseau GG, Hue L. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem J 2004; 381: 561-579 [PMID: 15170386 DOI: 10.1042/BJ20040752]
21. Sakata J, Abe Y, Uyeda K. Molecular cloning of the DNA and expression and characterization of rat testes fructose-6-phosphate,2-kinase: fructose-2,6-bisphosphatase. J Biol Chem 1991; 266: 15764-15770 [PMID: 1651918]
22. Manzano A, Rosa JL, Ventura F, Pérez JX, Nadal M, Estivill X, Ambrosio S, Gil J, Bartrons R. Molecular cloning, expression, and chromosomal localization of a ubiquitously expressed human 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase gene (PFKFB3). Cytogenet Cell Genet 1998; 83: 214-217 [PMID: 10072580 DOI: 10.1159/000015181]
23. Sakakibara R, Okudaira T, Fujiwara K, Kato M, Hirata T, Yamanaka S, Naito M, Fukasawa M. Tissue distribution of placenta-type 6-phosphofructo- 2-kinase/fructose-2,6-bisphosphatase. Biochem Biophys Res Commun 1999; 257: 177-181 [PMID: 10092529]
24. Minchenko O, Opentanova I, Caro J. Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo. FEBS Lett 2003; 554: 264-270 [PMID: 14623077 DOI: 10.1016/S0014-5793(03)01179-7]
25. Minchenko O, Opentanova I, Minchenko D, Ogura T, Esumi H. Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation. FEBS Lett 2004; 576: 14-20 [PMID: 15474002 DOI: 10.1016/j.febslet.2004.08.053]
26. Chesney J . 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis. Curr Opin Clin Nutr Metab Care 2006; 9: 535-539 [PMID: 16912547]
27. Minchenko A, Leshchinsky I, Opentanova I, Sang N, Srinivas V, Armstead V, Caro J. Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem 2002; 277: 6183-6187 [PMID: 11744734]
28. Chesney J, Mitchell R, Benigni F, Bacher M, Spiegel L, Al-Abed Y, Han JH, Metz C, Bucala R. An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc Natl Acad Sci USA 1999; 96: 3047-3052 [PMID: 10077634]
29. Atsumi T, Chesney J, Metz C, Leng L, Donnelly S, Makita Z, Mitchell R, Bucala R. High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res 2002; 62: 5881-5887 [PMID: 12384552]
30. Minchenko OH, Ogura T, Opentanova IL, Minchenko DO, Ochiai A, Caro J, Komisarenko SV, Esumi H. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family overexpression in human lung tumor. Ukr Biokhim Zh 2005; 77: 46-50 [PMID: 19618741]
31. Minchenko OH, Opentanova IL, Ogura T, Minchenko DO, Komisarenko SV, Caro J, Esumi H. Expression and hypoxia-responsiveness of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 in mammary gland malignant cell lines. Acta Biochim Pol 2005; 52: 881-888 [PMID: 16025159]
32. Bobarykina AY, Minchenko DO, Opentanova IL, Moenner M, Caro J, Esumi H, Minchenko OH. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers. Acta Biochim Pol 2006; 53: 789-799 [PMID: 17143338]
33. Minchenko OH, Ochiai A, Opentanova IL, Ogura T, Minchenko DO, Caro J, Komisarenko SV, Esumi H. Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors. Biochimie 2005; 87: 1005-1010 [PMID: 15925437 DOI: 10.1016/j/biochip.2005.04.007]
34. Yalcin A, Clem BF, Simmons A, Lane A, Nelson K, Clem AL, Brock E, Siow D, Wattenberg B, Telang S, Chesney J. Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J Biol Chem 2009; 284: 24223-24232 [PMID: 19473963 DOI: 10.1074/jbc.M109.016816]
35. Kessler R, Bleichert F, Warnke JP, Eschrich K. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) is upregulated in high-grade astrocytomas. J Neurooncol 2008; 86: 257-264 [PMID: 17805487 DOI: 10.1007/s11060-007-9471-7]
36. Fukasawa M, Tsuchiya T, Takayama E, Shinomiya N, Uyeda K, Sakakibara R, Seki S. Identification and characterization of the hypoxia-responsive element of the human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene. J Biochem 2004; 136: 273-277 [PMID: 15598882 DOI: 10.1093/jb/mvhl37]
37. Obach M, Navarro-Sabaté A, Caro J, Kong X, Duran J, Gómez M, Perales JC, Ventura F, Rosa JL, Bartrons R. 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia. J Biol Chem 2004; 279: 53562-53570 [PMID: 15466858 DOI: 10.1074/jbc.M406096200]
38. Marsin AS, Bouzin C, Bertrand L, Hue L. The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J Biol Chem 2002; 277: 30778-30783 [PMID: 12065600 DOI: 10.1074/jbc.M205213200]
39. Hue L, Beauloye C, Bertrand L, Horman S, Krause U, Marsin AS, Meisse D, Vertommen D, Rider MH. New targets of AMP-activated protein kinase. Biochem Soc Trans 2003; 31: 213-215 [PMID: 12546687]
40. Bando H, Atsumi T, Nishio T, Niwa H, Mishima S, Shimizu C, Yoshioka N, Bucala R, Koike T. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer. Clin Cancer Res 2005; 11: 5784-5792 [PMID: 16115917 DOI: 10.1158/1078-0432.CCR-05-0149]
41. Novellasdemunt L, Bultot L, Manzano A, Ventura F, Rosa JL, Vertommen D, Rider MH, Navarro-Sabate À, Bartrons R. PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli. Biochem J 2013; 452: 531-543 [PMID: 23548149 DOI: 10.1042/BJ20121886]
42. Almeida A, Bolaños JP, Moncada S. E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. Proc Natl Acad Sci USA 2010; 107: 738-741 [PMID: 20080744 DOI: 10.1073/pnas.0913668107]
43. Cordero-Espinoza L, Hagen T. Increased concentrations of fructose 2,6-bisphosphate contribute to the Warburg effect in phosphatase and tensin homolog (PTEN)-deficient cells. J Biol Chem 2013; 288: 36020-36028 [PMID: 24169697 DOI: 10.1074/jbc.M113.510289]
44. Tudzarova S, Colombo SL, Stoeber K, Carcamo S, Williams GH, Moncada S. Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-beta-TrCP, sequentially regulate glycolysis during the cell cycle. Proc Natl Acad Sci USA 2011; 108: 5278-5283 [PMID: 21402913 DOI: 10.1073/pnas.1102247108]
45. Moon JS, Jin WJ, Kwak JH, Kim HJ, Yun MJ, Kim JW, Park SW, Kim KS. Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells. Biochem J 2011; 433: 225-233 [PMID: 20958264 DOI: 10.1042/BJ20101104]
46. Ruiz-García A, Monsalve E, Novellasdemunt L, Navarro-Sabaté A, Manzano A, Rivero S, Castrillo A, Casado M, Laborda J, Bartrons R, Díaz-Guerra MJ. Cooperation of adenosine with macrophage Toll-4 receptor agonists leads to increased glycolytic flux through the enhanced expression of PFKFB3 gene. J Biol Chem 2011; 286: 19247-19258 [PMID: 21464136 DOI: 10.1074/jbc.M110.190298]
47. Kumar P, Sharoyko VV, Spégel P, Gullberg U, Mulder H, Olsson I, Ajore R. The transcriptional co-repressor myeloid translocation gene 16 inhibits glycolysis and stimulates mitochondrial respiration. PLoS One 2013; 8: e68502 [PMID: 23840896 DOI: 10.1371/journal.pone.0068502]
48. Zscharnack K, Kessler R, Bleichert F, Warnke JP, Eschrich K. The PFKFB3 splice variant UBI2K4 is downregulated in high-grade astrocytomas and impedes the growth of U87 glioblastoma cells. Neuropathol Appl Neurobiol 2009; 35: 566-578 [PMID: 19490427 DOI: 10.1111/j.1365-2990.2009.01027.x]
49. Atsumi T, Nishio T, Niwa H, Takeuchi J, Bando H, Shimizu C, Yoshioka N, Bucala R, Koike T. Expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase/PFKFB3 isoforms in adipocytes and their potential role in glycolytic regulation. Diabetes 2005; 54: 3349-3357 [PMID: 16306349 DOI: 10.2337/diabetes.54.12.3349]
50. Mykhalchenko VG, Minchenko DO, Tsuchihara K, Moenner M, Komisarenko SV, Bikfalvi A, Esumi H, Minchenko OH. Expression of mouse 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 mRNA alternative splice variants in hypoxia. Ukr Biokhim Zh 2008; 80: 19-25 [PMID: 18710022]
51. Mykhalchenko VG, Tsuchihara K, Minchenko DO, Esumi H, Prystupiuk OM, Minchenko OH. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase mRNA expression in streptozotocin-diabetic rats. Biopolymers Cell 2008; 24: 260-266 [DOI: 10.7124/bc.0007A9]
52. Ros S, Santos CR, Moco S, Baenke F, Kelly G, Howell M, Zamboni N, Schulze A. Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival. Cancer Discov 2012; 2: 328-343 [PMID: 22576210 DOI: 10.1158/2159-8290.CD-11-0234]
53. Jeon YK, Yoo DR, Jang YH, Jang SY, Nam MJ. Sulforaphane induces apoptosis in human hepatic cancer cells through inhibition of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase4, mediated by hypoxia inducible factor-1-dependent pathway. Biochim Biophys Acta 2011; 1814: 1340-1348 [PMID: 21640852 DOI: 10.1016/j.bbapap.2011.05.015]
54. Goidts V, Bageritz J, Puccio L, Nakata S, Zapatka M, Barbus S, Toedt G, Campos B, Korshunov A, Momma S, Van Schaftingen E, Reifenberger G, Herold-Mende C, Lichter P, Radlwimmer B. RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival. Oncogene 2012; 31: 3235-3243 [PMID: 22056879 DOI: 10.1038/onc.2011.490]
55. Yun SJ, Jo SW, Ha YS, Lee OJ, Kim WT, Kim YJ, Lee SC, Kim WJ. PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer. Urol Oncol 2012; 30: 893-899 [PMID: 21396842 DOI: 10.1016/j.urolonc.2010.08.018]
56. Dang CV. Cancer cell metabolism: there is no ROS for the weary. Cancer Discov 2012; 2: 304-307 [PMID: 22576206 DOI: 10.1158/2159-8290.CD-12-0069]
57. Dang CV. Links between metabolism and cancer. Genes Dev 2012; 26: 877-890 [PMID: 22549953 DOI: 10.1101/gad.189365.112]
58. Minchenko OH, Ogura T, Opentanova IL, Minchenko DO, Esumi H. Splice isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4: expression and hypoxic regulation. Mol Cell Biochem 2005; 280: 227-234 [PMID: 16311927]
59. Minchenko DO, Mykhalchenko VG, Tsuchihara K, Kanehara S, Yavorovsky OP, Zavgorodny IV, Paustovsky YO, Komisarenko SV, Esumi H, Minchenko OH. Alternative splice variants of rat 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase-4 mRNA. Ukr Biokhim Zh 2008; 80: 66-73 [PMID: 19140452]
60. Minchenko DO, Kovtun OO, Minchenko OH, Byts YV. Family of alternative splice variants of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 mRNA. Nauk Visnyk Bogomolets Natl Med Univ 2006; 15: 72-78
61. Liu Z, Jia X, Duan Y, Xiao H, Sundqvist KG, Permert J, Wang F. Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration. Cancer Biol Ther 2013; 14: 428-435 [PMID: 23377827 DOI: 10.4161/cbt.23786]
62. Seagroves TN, Ryan HE, Lu H, Wouters BG, Knapp M, Thibault P, Laderoute K, Johnson RS. Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol Cell Biol 2001; 21: 3436-3444 [PMID: 11313469]
63. Gleadle JM, Ratcliffe PJ. Hypoxia and the regulation of gene expression. Mol Med Today 1998; 4: 122-129 [PMID: 9575495]
64. Minchenko A, Caro J. Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element. Mol Cell Biochem 2000; 208: 53-62 [PMID: 10939628]
65. Bobarykina AIu, Minchenko DO, Opentanova IL, Kovtun OO, Komisarenko SV, Esumi H, Minchenko OH. [HIF-1alpha, HIF-2alpha and VHL mRNA expression in different cell lines during hypoxia]. Ukr Biokhim Zh 2006; 78: 62-72 [PMID: 17100286]
66. Uchida T, Rossignol F, Matthay MA, Mounier R, Couette S, Clottes E, Clerici C. Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha. J Biol Chem 2004; 279: 14871-14878 [PMID: 14744852 DOI: 10.1074/jbc.M400461200]
67. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 2002; 295: 858-861 [PMID: 11823643]
68. Mole DR, Schlemminger I, McNeill LA, Hewitson KS, Pugh CW, Ratcliffe PJ, Schofield CJ. 2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase. Bioorg Med Chem Lett 2003; 13: 2677-2680 [PMID: 12873492]
69. Minchenko DO, Bobarykina AY, Senchenko TY, Hubenya OV, Tsuchihara K, Ochiai A, Moenner M, Esumi H, Minchenko OH. Expression of the VEGF, Glut1 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 and -4 in human cancers of the lung, colon and stomach. Studia Biologica 2009; 3: 25-34
70. Ji D, Lu ZT, Li YQ, Liang ZY, Zhang PF, Li C, Zhang JL, Zheng X, Yao YM. MACC1 expression correlates with PFKFB2 and survival in hepatocellular carcinoma. Asian Pac J Cancer Prev 2014; 15: 999-1003 [PMID: 24568531]
71. Novellasdemunt L, Tato I, Navarro-Sabate A, Ruiz-Meana M, Méndez-Lucas A, Perales JC, Garcia-Dorado D, Ventura F, Bartrons R, Rosa JL. Akt-dependent activation of the heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB2) isoenzyme by amino acids. J Biol Chem 2013; 288: 10640-10651 [PMID: 23457334 DOI: 10.1074/jbc.M113.455998]
72. Moenner M, Pluquet O, Bouchecareilh M, Chevet E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res 2007; 67: 10631-10634 [PMID: 18006802 DOI: 10.1158/0008-5472.CAN-07-1705]
73. Auf G, Jabouille A, Guérit S, Pineau R, Delugin M, Bouchecareilh M, Magnin N, Favereaux A, Maitre M, Gaiser T, von Deimling A, Czabanka M, Vajkoczy P, Chevet E, Bikfalvi A, Moenner M. Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma. Proc Natl Acad Sci USA 2010; 107: 15553-15558 [PMID: 20702765 DOI: 10.1073/pnas.0914072107]
74. Auf G, Jabouille A, Delugin M, Guérit S, Pineau R, North S, Platonova N, Maitre M, Favereaux A, Vajkoczy P, Seno M, Bikfalvi A, Minchenko D, Minchenko O, Moenner M. High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor. BMC Cancer 2013; 13: 597 [PMID: 24330607 DOI: 10.1186/1471-2407-13-597]
75. Wang S, Kaufman RJ. The impact of the unfolded protein response on human disease. J Cell Biol 2012; 197: 857-867 [PMID: 22733998 DOI: 10.1083/jcb.201110131]
76. Koumenis C. ER stress, hypoxia tolerance and tumor progression. Curr Mol Med 2006; 6: 55-69 [PMID: 16472113 DOI: 10.2174/156652406775574604]
77. Minchenko DO, Marunych RY, Khomenko EV, Bakalets TV, Minchenko OH. Expression of hexokinase and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase genes in ERN1 knockdown glioma U87 cells: effect of hypoxia and glutamine or glucose deprivation. Studia Biologica 2011; 5: 5-18
78. De Bock K, Georgiadou M, Schoors S, Kuchnio A, Wong BW, Cantelmo AR, Quaegebeur A, Ghesquière B, Cauwenberghs S, Eelen G, Phng LK, Betz I, Tembuyser B, Brepoels K, Welti J, Geudens I, Segura I, Cruys B, Bifari F, Decimo I, Blanco R, Wyns S, Vangindertael J, Rocha S, Collins RT, Munck S, Daelemans D, Imamura H, Devlieger R, Rider M, Van Veldhoven PP, Schuit F, Bartrons R, Hofkens J, Fraisl P, Telang S, Deberardinis RJ, Schoonjans L, Vinckier S, Chesney J, Gerhardt H, Dewerchin M, Carmeliet P. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 2013; 154: 651-663 [PMID: 23911327 DOI: 10.1016/j.cell.2013.06.037]
79. Minchenko DO, Kubajchuk KI, Ratushna OO, Komisarenko SV, Minchenko OH. The effect of hypoxia and ischemic condition on the expression of VEGF genes in glioma U87 cells is dependent from ERN1 knockdown. Adv Biol Chem 2011; 2: 198-206 [DOI: 10.4236/abc.2012.22024]
80. Schoors S, De Bock K, Cantelmo AR, Georgiadou M, Ghesquière B, Cauwenberghs S, Kuchnio A, Wong BW, Quaegebeur A, Goveia J, Bifari F, Wang X, Blanco R, Tembuyser B, Cornelissen I, Bouché A, Vinckier S, Diaz-Moralli S, Gerhardt H, Telang S, Cascante M, Chesney J, Dewerchin M, Carmeliet P. Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis. Cell Metab 2014; 19: 37-48 [PMID: 24332967 DOI: 10.1016/j.cmet.2013.11.008]
81. Eelen G, Cruys B, Welti J, De Bock K, Carmeliet P. Control of vessel sprouting by genetic and metabolic determinants. Trends Endocrinol Metab 2013; 24: 589-596 [PMID: 24075830 DOI: 10.1016/j.tem.2013.08.006]
82. Mace TA, Collins AL, Wojcik SE, Croce CM, Lesinski GB, Bloomston M. Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells. J Surg Res 2013; 184: 855-860 [PMID: 23726431 DOI: 10.1016/j.jss.2013.04.061]
83. Kitamoto S, Yokoyama S, Higashi M, Yamada N, Takao S, Yonezawa S. MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors. Oncogene 2013; 32: 4614-4621 [PMID: 23108411 DOI: 10.1038/onc.2012.478]
84. Uh MK, Kandel J, Kitajewski J. Evaluating tumor angiogenesis. Methods Mol Biol 2013; 980: 341-351 [PMID: 23359165 DOI: 10.1007/978-1-62703-287-2-20]
85. Tung KH, Lin CW, Kuo CC, Li LT, Kuo YH, Lin CW, Wu HC. CHC promotes tumor growth and angiogenesis through regulation of HIF-α and VEGF signaling. Cancer Lett 2013; 331: 58-67 [PMID: 23228632 DOI: 10.1016/j.canlet.2012.12.001]
86. Kappler M, Taubert H, Schubert J, Vordermark D, Eckert AW. The real face of HIF1α in the tumor process. Cell Cycle 2012; 11: 3932-3936 [PMID: 22987151 DOI: 10.4161/cc.21854]
87. Bolaños JP. Adapting glycolysis to cancer cell proliferation: the MAPK pathway focuses on PFKFB3. Biochem J 2013; 452: e7-e9 [PMID: 23725459 DOI: 10.1042/BJ20130560]
88. Sahraei M, Roy LD, Curry JM, Teresa TL, Nath S, Besmer D, Kidiyoor A, Dalia R, Gendler SJ, Mukherjee P. MUC1 regulates PDGFA expression during pancreatic cancer progression. Oncogene 2012; 31: 4935-4945 [PMID: 22266848 DOI: 10.1038/onc.2011.651]
89. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, Story M, Le QT, Giaccia AJ. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 2009; 35: 856-867 [PMID: 19782034 DOI: 10.1016/j.molcel.2009.09.006]
90. Shi CY, Fan Y, Liu B, Lou WH. HIF1 contributes to hypoxia-induced pancreatic cancer cells invasion via promoting QSOX1 expression. Cell Physiol Biochem 2013; 32: 561-568 [PMID: 24008827 DOI: 10.1159/000354460]
91. Clem BF, O'Neal J, Tapolsky G, Clem AL, Imbert-Fernandez Y, Kerr DA, Klarer AC, Redman R, Miller DM, Trent JO, Telang S, Chesney J. Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer. Mol Cancer Ther 2013; 12: 1461-1470 [PMID: 23674815 DOI: 10.1158/1535-7163.MCT-13-0097]
92. Seo M, Kim JD, Neau D, Sehgal I, Lee YH. Structure-based development of small molecule PFKFB3 inhibitors: a framework for potential cancer therapeutic agents targeting the Warburg effect. PLoS One 2011; 6: e24179 [PMID: 21957443 DOI: 10.1371/journal.pone.0024179]
93. Klarer AC, O'Neal J, Imbert-Fernandez Y, Clem A, Ellis SR, Clark J, Clem B, Chesney J, Telang S. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism. Cancer Metab 2014; 2: 2 [PMID: 24451478 DOI: 10.1186/2049-3002-2-2]
94. Yang Z, Goronzy JJ, Weyand CM. The glycolytic enzyme PFKFB3/phosphofructokinase regulates autophagy. Autophagy 2014; 10: 382-383 [PMID: 24351650]
95. Minchenko DO, Bobarykina AY, Ratushna OO, Marunych RY, Tsuchihara K, Moenner M, Caro J, Esumi H, Minchenko OH. Dominant-negative constructs of human 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 and -4: effect on the expression of endogenous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase mRNA. Biotechnology 2008; 1: 49-56